ISSN 1725-2423
Official Journal
of the European Union
C 209
English edition
Information and Notices
Volume 48
26 August 2005
|
ISSN 1725-2423 |
||
|
Official Journal of the European Union |
C 209 |
|
|
|
||
|
English edition |
Information and Notices |
Volume 48 |
|
Notice No |
Contents |
page |
|
|
I Information |
|
|
|
Commission |
|
|
2005/C 209/1 |
||
|
2005/C 209/2 |
Notice of the impending expiry of certain anti-dumping measures |
|
|
2005/C 209/3 |
||
|
EN |
|
I Information
Commission
|
26.8.2005 |
EN |
Official Journal of the European Union |
C 209/1 |
Euro exchange rates (1)
25 August 2005
(2005/C 209/01)
1 euro=
|
|
Currency |
Exchange rate |
|
USD |
US dollar |
1,2272 |
|
JPY |
Japanese yen |
135,02 |
|
DKK |
Danish krone |
7,4573 |
|
GBP |
Pound sterling |
0,68200 |
|
SEK |
Swedish krona |
9,3313 |
|
CHF |
Swiss franc |
1,5478 |
|
ISK |
Iceland króna |
77,89 |
|
NOK |
Norwegian krone |
7,9255 |
|
BGN |
Bulgarian lev |
1,9557 |
|
CYP |
Cyprus pound |
0,5729 |
|
CZK |
Czech koruna |
29,698 |
|
EEK |
Estonian kroon |
15,6466 |
|
HUF |
Hungarian forint |
245,60 |
|
LTL |
Lithuanian litas |
3,4528 |
|
LVL |
Latvian lats |
0,6961 |
|
MTL |
Maltese lira |
0,4293 |
|
PLN |
Polish zloty |
4,0430 |
|
RON |
Romanian leu |
3,5144 |
|
SIT |
Slovenian tolar |
239,50 |
|
SKK |
Slovak koruna |
38,865 |
|
TRY |
Turkish lira |
1,6760 |
|
AUD |
Australian dollar |
1,6173 |
|
CAD |
Canadian dollar |
1,4621 |
|
HKD |
Hong Kong dollar |
9,5376 |
|
NZD |
New Zealand dollar |
1,7575 |
|
SGD |
Singapore dollar |
2,0521 |
|
KRW |
South Korean won |
1 256,90 |
|
ZAR |
South African rand |
7,9609 |
|
CNY |
Chinese yuan renminbi |
9,9406 |
|
HRK |
Croatian kuna |
7,3865 |
|
IDR |
Indonesian rupiah |
12 670,84 |
|
MYR |
Malaysian ringgit |
4,625 |
|
PHP |
Philippine peso |
68,785 |
|
RUB |
Russian rouble |
34,9710 |
|
THB |
Thai baht |
50,409 |
Source: reference exchange rate published by the ECB.
|
26.8.2005 |
EN |
Official Journal of the European Union |
C 209/2 |
Notice of the impending expiry of certain anti-dumping measures
(2005/C 209/02)
|
1. |
As provided for in Article 11(2) of Council Regulation (EC) No 384/96 of 22 December 1995 (1) on protection against dumped imports from countries not members of the European Community, the Commission gives notice that, unless a review is initiated in accordance with the following procedure, the anti-dumping measures mentioned below will expire on the date mentioned in the table below. |
2. Procedure
Community producers may lodge a written request for a review. This request must contain sufficient evidence that the expiry of the measures would be likely to result in a continuation or recurrence of dumping and injury.
Should the Commission decide to review the measures concerned, importers, exporters, representatives of the exporting country and Community producers will then be provided with the opportunity to amplify, rebut or comment on the matters set out in the review request.
3. Time limit
Community producers may submit a written request for a review on the above basis, to reach the European Commission, Directorate-General for Trade (Division B-1), J-79 5/16, B-1049 Brussels (2) at any time from the date of the publication of the present notice but no later than three months before the date mentioned in the table below.
|
4. |
This notice is published in accordance with Article 11(2) of Council Regulation (EC) No 384/96 of 22 December 1995. |
|
Product |
Country(ies) of origin or exportation |
Measures |
Reference |
Date of expiry |
|
Urea |
Russia |
Anti-dumping duty |
Council Regulation (EC) No 901/2001 (OJ L 127, 9.5.2001, p. 11) |
10.5.2006 |
|
Aluminium foil |
People's Republic of China Russia |
Anti-dumping duty |
Council Regulation (EC) No 950/2001 (OJ L 134, 17.5.2001, p. 1) as last amended by Regulation (EC) No 998/2004 (OJ L 183, 20.5.2004, p. 4) |
18.5.2006 |
|
Russia |
Undertaking |
Commission Decision No 2001/381/EC (OJ L 134, 17.5.2001, p. 67) |
18.5.2006 |
(1) OJ L 56, 6.3.1996, p. 1. Regulation as last amended by Council Regulation (EC) No 461/2004 (OJ L 77, 13.3.2004, p. 12).
(2) Telefax : (32-2) 295 65 05.
|
26.8.2005 |
EN |
Official Journal of the European Union |
C 209/3 |
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2005 to 31 July 2005
(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93 (1))
(2005/C 209/03)
— Modification of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93): Accepted
|
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|
4.7.2005 |
Apidra |
Aventis Pharma Deutschland GmbH, Brueningstrasse 50, D-65926 Frankfurt am Main |
EU/1/04/285/001-028 |
6.7.2005 |
|
4.7.2005 |
Forcaltonin |
Unigene UK Limited, 63 High Road, Bushey Heath, Herts, WD2 1EE, United Kingdom |
EU/1/98/093/002 |
6.7.2005 |
|
4.7.2005 |
Trisenox |
Cell Therapeutics (UK) Ltd, 100 Pall Mall, London SW1Y 5HP, United Kingdom |
EU/1/02/204/001 |
6.7.2005 |
|
4.7.2005 |
Levemir |
Novo Nordisk A/S, Novo Allé, DK-2880 Bagsværd |
EU/1/04/278/001-009 |
6.7.2005 |
|
4.7.2005 |
Zerene |
Wyeth Research (UK) Limited, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom |
EU/1/99/099/001-006 |
6.7.2005 |
|
4.7.2005 |
Sonata |
Wyeth Europa Limited, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom |
EU/1/99/102/001-008 |
6.7.2005 |
|
4.7.2005 |
Cymbalta |
Eli Lilly Nederland BV, Grootslag 1-5, 3991 RA Houten, Nederland |
EU/1/04/296/001-006 |
6.7.2005 |
|
4.7.2005 |
Cymbalta |
Eli Lilly Nederland BV, Grootslag 1-5, 3991 RA Houten, Nederland |
EU/1/04/296/001-006 |
6.7.2005 |
|
4.7.2005 |
Xeristar |
Boehringer Ingelheim International GmbH, Binger Strasse 173 — D-55216 Ingelheim am Rhein |
EU/1/04/297/001-006 |
6.7.2005 |
|
4.7.2005 |
Xeristar |
Boehringer Ingelheim International GmbH, Binger Strasse 173 — D-55216 Ingelheim am Rhein |
EU/1/04/297/001-006 |
6.7.2005 |
|
4.7.2005 |
Visudyne |
Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom |
EU/1/00/140/001 |
6.7.2005 |
|
4.7.2005 |
Xigris |
Eli Lilly Nederland BV, Grootslag 1-5, 3991 RA Houten, Nederland |
EU/1/02/225/001-002 |
6.7.2005 |
|
7.7.2005 |
Invanz |
Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom |
EU/1/02/216/001-002 |
11.7.2005 |
|
7.7.2005 |
Arixtra |
Glaxo Group Ltd, Greenford, Middlesex UB6 0NN, United Kingdom |
EU/1/02/206/001-008 |
11.7.2005 |
|
7.7.2005 |
Quixidar |
Glaxo Group Ltd, Greenford, Middlesex UB6 0NN, United Kingdom |
EU/1/02/207/001-008 |
11.7.2005 |
|
7.7.2005 |
Cystagon |
Orphan Europe, Immeuble ‘Le Guillaumet’, F-92046 Paris La Défense |
EU/1/97/039/001-004 |
11.7.2005 |
|
8.7.2005 |
Glivec |
Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom |
EU/1/01/198/001-013 |
12.7.2005 |
|
8.7.2005 |
Aranesp |
Amgen Europe BV, Minervum 7061, 4817 ZK Breda, Nederland |
EU/1/01/185/001-056 |
12.7.2005 |
|
8.7.2005 |
Nespo |
Dompé Biotec SpA, Via San Martino, 12, I-20122 Milano |
EU/1/01/184/001-056 |
12.7.2005 |
|
8.7.2005 |
Lyrica |
PFIZER Ltd, Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom |
EU/1/04/279/030-032 |
12.7.2005 |
|
8.7.2005 |
Fortovase |
Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom |
EU/1/98/075/001-002 |
12.7.2005 |
|
8.7.2005 |
AVANDIA |
SmithKline Beecham plc, 980 Great West Road, Brentford, Middlesex, TW8 9GS United Kingdom |
EU/1/00/137/001-012 |
12.7.2005 |
|
8.7.2005 |
NovoRapid |
Novo Nordisk A/S, Novo Allé, DK-2880 Bagsværd |
EU/1/99/119/003 EU/1/99/119/005-007 EU/1/99/119/009-014 |
12.7.2005 |
|
8.7.2005 |
NeuroBloc |
Elan Pharma International Ltd., WIL House, Shannon Business Park, Shannon, County Clare, Ireland |
EU/1/00/166/001-003 |
13.7.2005 |
|
8.7.2005 |
Simulect |
Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom |
EU/1/98/084/001-002 |
12.7.2005 |
|
8.7.2005 |
Zevalin |
Schering AG, Müllerstrasse 170-178, D-13342 Berlin |
EU/1/03/264/001 |
12.7.2005 |
|
8.7.2005 |
Viread |
Gilead Sciences International Limited, Cambridge CB1 6GT United Kingdom |
EU/1/01/200/001 |
12.7.2005 |
|
8.7.2005 |
Keppra |
UCB SA, Allée de la recherche, 60, B-1070 Bruxelles/Researchdreef, 60, B-1070 Brussel |
EU/1/00/146/001-027 |
12.7.2005 |
|
8.7.2005 |
Lantus |
Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main |
EU/1/00/134/001-029 |
12.7.2005 |
|
8.7.2005 |
Optisulin |
Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main |
EU/1/00/133/001-008 |
12.7.2005 |
|
13.7.2005 |
NeoRecormon |
Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom |
EU/1/97/031/001-003 EU/1/97/031/019-046 |
15.7.2005 |
|
22.7.2005 |
Enbrel |
Wyeth Europa Limited, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom |
EU/1/99/126/001-011 |
26.7.2005 |
|
22.7.2005 |
KOGENATE Bayer |
Bayer AG, D-51368 Leverkusen |
EU/1/00/143/001-006 |
26.7.2005 |
|
27.7.2005 |
Vaniqa |
Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, United Kingdom |
EU/1/01/173/001-003 |
29.7.2005 |
|
27.7.2005 |
Infergen |
Yamanouchi Europe B.V., Elisabethhof 19, 2353 EW Leiderdorp, Nederland |
EU/1/98/087/001-003 |
29.7.2005 |
|
27.7.2005 |
Zevalin |
Schering AG, Müllerstrasse 170-178, D-13342 Berlin |
EU/1/03/264/001 |
29.7.2005 |
|
27.7.2005 |
Replagal |
TKT Europe AB, Rinkebyvägen 11B, S-182 36 Danderyd |
EU/1/01/189/001-006 |
29.7.2005 |
|
27.7.2005 |
Velcade |
Janssen-Cilag International NV, Turnhoutseweg, 30 B-2340 Beerse |
EU/1/04/274/001 |
29.7.2005 |
|
27.7.2005 |
AVANDIA |
SmithKline Beecham plc, 980 Great West Road, Brentford, Middlesex, TW8 9GS United Kingdom |
EU/1/00/137/001-012 |
29.7.2005 |
|
27.7.2005 |
ReFacto |
Wyeth Europa Ltd., Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom |
EU/1/99/103/001-004 |
29.7.2005 |
|
28.7.2005 |
Kineret |
Amgen Europe BV, Minervum 7061, 4817 ZK Breda, Nederland |
EU/1/02/203/001-004 |
1.8.2005 |
— Issuing of a marketing authorization (Article 34 of Council Regulation (EEC) No 2309/93): Accepted
|
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|
8.7.2005 |
Equilis Prequenza |
Intervet International BV, Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland |
EU/2/05/056/001-002 |
12.7.2005 |
|
8.7.2005 |
Equilis Prequenza Te |
Intervet International BV, Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland |
EU/2/05/057/001-002 |
12.7.2005 |
|
8.7.2005 |
Equilis Te |
Intervet International BV, Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland |
EU/2/05/055/001-002 |
12.7.2005 |
|
27.7.2005 |
Profender |
Bayer Healthcare AG, D-51368 Leverkusen |
EU/2/05/054/001-017 |
29.7.2005 |
— Modification of a marketing authorization (Article 34 of Council Regulation (EEC) No 2309/93): Accepted
|
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|
7.7.2005 |
Neocolipor |
Merial, 29 avenue Tony Garnier, F-69007 Lyon |
EU/2/98/008/001-004 |
11.7.2005 |
|
8.7.2005 |
Ibaflin |
Intervet International BV, Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland |
EU/2/00/022/001a-001b, 002a-002b, 003a-003b, 004a-004b, EU/2/00/022/005-017, |
12.7.2005 |
Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:
|
The European Medicines Agency |
|
7, Westferry Circus, Canary Wharf |
|
London E14 4HB |
|
United Kingdom |
(1) OJ L 214 of 24.8.1993, p. 1.